Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma-Reference-Cited by-同舟云学术

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

Published:2013-01-24 Issue:2 Volume:2 Page:185-195
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lou Emil¹,Peters Katherine B.²,Sumrall Ashley L.²,Desjardins Annick²,Reardon David A.³,Lipp Eric S.¹,Herndon James E.⁴,Coan April⁴,Bailey Leighann²,Turner Scott¹,Friedman Henry S.⁵,Vredenburgh James J.²

Affiliation:

1. The Preston Robert Tisch Brain Tumor Center at Duke Department of Surgery Duke University Medical Center Durham North Carolina

2. The Preston Robert Tisch Brain Tumor Center at Duke Department of Medicine Duke University Medical Center Durham North Carolina

3. Center for Neuro‐Oncology Dana‐Farber Cancer Institute Boston Massachusetts

4. Cancer Center Department of Biostatistics Duke University Medical Center Durham North Carolina

5. The Preston Robert Tisch Brain Tumor Center at Duke Department of Surgery and Pediatrics Duke University Medical Center Durham North Carolina

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.58

Reference37 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach

3. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas

4. Value of Surgical Intervention in the Treatment of Glioma

5. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling and simulation of anisotropic growth in brain tumours through poroelasticity: A study of ventricular compression and therapeutic protocols;Computational Mechanics;2024-04-25

2. State of the neoadjuvant therapy for glioblastoma multiforme—Where do we stand?;Neuro-Oncology Advances;2024-01-01

3. Prognostic factors affecting outcome of multifocal or multicentric glioblastoma: A scoping review;Journal of Neurosciences in Rural Practice;2022-12-15

4. Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma;Cell Death & Disease;2022-08-18

5. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma;Signal Transduction and Targeted Therapy;2022-02-02